Rain Therapeutics

company

About

Rain Therapeutics is a operator of a clinical stage biotechnology company.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$18.36M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Rain Therapeutics develops targeted therapies for patients with cancer. We begin by identifing cancers with a single, and clear, oncogenic driver and evaluating sub-populations of cancer populations with an unmet need, where standards of care are ineffective. Our global scientific and thought-leader network drives our asset and technology identification to match these cancers with small molecule therapeutics targeted at treating specific cancer mutations.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$18.36M
Rain Therapeutics has raised a total of $18.36M in funding over 2 rounds. Their latest funding was raised on May 21, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 21, 2018 Series A $18.36M 1 Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Rain Therapeutics has made 2 investments. Their most recent investment was on Nov 11, 2015, when MONI raised $1.75M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 11, 2015 MONI
Seed $1.75M FinTech
Jan 6, 2015 fitmob
Series B $5M Communities

Investors

Number of Lead Investors
Number of Investors
1
Rain Therapeutics is funded by 1 investors. University of Auckland Inventors Fund are the most recent investors.
Investor Name Lead Investor Funding Round
University of Auckland Inventors Fund Series A